373 related articles for article (PubMed ID: 29697036)
1. Dosimetry and Radiobiology of Alpha-Particle Emitting Radionuclides.
Sgouros G; Hobbs R; Josefsson A
Curr Radiopharm; 2018; 11(3):209-214. PubMed ID: 29697036
[TBL] [Abstract][Full Text] [Related]
2. Targeted alpha therapy: part I.
Elgqvist J
Curr Radiopharm; 2011 Jul; 4(3):176. PubMed ID: 22201706
[TBL] [Abstract][Full Text] [Related]
3. The Case for Dosimetry in Alpha-Emitter Therapy.
Sgouros G
J Med Imaging Radiat Sci; 2019 Dec; 50(4 Suppl 1):S45-S46. PubMed ID: 31537496
[TBL] [Abstract][Full Text] [Related]
4. Dosimetry, Radiobiology and Synthetic Lethality: Radiopharmaceutical Therapy (RPT) With Alpha-Particle-Emitters.
Sgouros G
Semin Nucl Med; 2020 Mar; 50(2):124-132. PubMed ID: 32172797
[TBL] [Abstract][Full Text] [Related]
5. Imaging and dosimetry for alpha-particle emitter radiopharmaceutical therapy: improving radiopharmaceutical therapy by looking into the black box.
Sgouros G; Frey E; Du Y; Hobbs R; Bolch W
Eur J Nucl Med Mol Imaging; 2021 Dec; 49(1):18-29. PubMed ID: 34782911
[TBL] [Abstract][Full Text] [Related]
6. An Overview of Targeted Alpha Therapy with
Morgenstern A; Apostolidis C; Kratochwil C; Sathekge M; Krolicki L; Bruchertseifer F
Curr Radiopharm; 2018; 11(3):200-208. PubMed ID: 29732998
[TBL] [Abstract][Full Text] [Related]
7. Targeted and Nontargeted α-Particle Therapies.
McDevitt MR; Sgouros G; Sofou S
Annu Rev Biomed Eng; 2018 Jun; 20():73-93. PubMed ID: 29345977
[TBL] [Abstract][Full Text] [Related]
8. MIRD Pamphlet No. 22 (abridged): radiobiology and dosimetry of alpha-particle emitters for targeted radionuclide therapy.
Sgouros G; Roeske JC; McDevitt MR; Palm S; Allen BJ; Fisher DR; Brill AB; Song H; Howell RW; Akabani G; ; Bolch WE; Brill AB; Fisher DR; Howell RW; Meredith RF; Sgouros G; Wessels BW; Zanzonico PB
J Nucl Med; 2010 Feb; 51(2):311-28. PubMed ID: 20080889
[TBL] [Abstract][Full Text] [Related]
9. Development of a transmission alpha particle dosimetry technique using A549 cells and a Ra-223 source for targeted alpha therapy.
Al Darwish R; Staudacher AH; Li Y; Brown MP; Bezak E
Med Phys; 2016 Nov; 43(11):6145. PubMed ID: 27806616
[TBL] [Abstract][Full Text] [Related]
10. Development of Targeted Alpha Particle Therapy for Solid Tumors.
Tafreshi NK; Doligalski ML; Tichacek CJ; Pandya DN; Budzevich MM; El-Haddad G; Khushalani NI; Moros EG; McLaughlin ML; Wadas TJ; Morse DL
Molecules; 2019 Nov; 24(23):. PubMed ID: 31779154
[TBL] [Abstract][Full Text] [Related]
11. The Evolving Clinical Role of Actinium-225 and Bismuth-213 for Targeted Alpha Therapy (TAT) - Production, Radiopharmaceutical Development and Clinical Applications.
Radchenko V; Schaffer P; Knapp FFR
Curr Radiopharm; 2018; 11(3):154-155. PubMed ID: 30378473
[No Abstract] [Full Text] [Related]
12. Modeling Cell and Tumor-Metastasis Dosimetry with the Particle and Heavy Ion Transport Code System (PHITS) Software for Targeted Alpha-Particle Radionuclide Therapy.
Lee D; Li M; Bednarz B; Schultz MK
Radiat Res; 2018 Sep; 190(3):236-247. PubMed ID: 29944461
[TBL] [Abstract][Full Text] [Related]
13. Radioimmunotherapy with alpha-particle emitting radionuclides.
Zalutsky MR; Pozzi OR
Q J Nucl Med Mol Imaging; 2004 Dec; 48(4):289-96. PubMed ID: 15640792
[TBL] [Abstract][Full Text] [Related]
14. Radioimmunotherapy with α-particle-emitting radionuclides.
Seidl C
Immunotherapy; 2014; 6(4):431-58. PubMed ID: 24815783
[TBL] [Abstract][Full Text] [Related]
15. Alpha-emitters for immuno-therapy: a review of recent developments from chemistry to clinics.
Huclier-Markai S; Alliot C; Varmenot N; Cutler CS; Barbet J
Curr Top Med Chem; 2012; 12(23):2642-54. PubMed ID: 23339760
[TBL] [Abstract][Full Text] [Related]
16. Alpha-particles for targeted therapy.
Sgouros G
Adv Drug Deliv Rev; 2008 Sep; 60(12):1402-6. PubMed ID: 18541332
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity of dose distribution in normal tissues in case of radiopharmaceutical therapy with alpha-emitting radionuclides.
Li WB; Bouvier-Capely C; Saldarriaga Vargas C; Andersson M; Madas B
Radiat Environ Biophys; 2022 Nov; 61(4):579-596. PubMed ID: 36239799
[TBL] [Abstract][Full Text] [Related]
18. Modelling and dosimetry for alpha-particle therapy.
Sgouros G; Hobbs RF; Song H
Curr Radiopharm; 2011 Jul; 4(3):261-5. PubMed ID: 22201712
[TBL] [Abstract][Full Text] [Related]
19. Pretargeted radioimmunotherapy with α-particle emitting radionuclides.
Lindegren S; Frost SH
Curr Radiopharm; 2011 Jul; 4(3):248-60. PubMed ID: 22201711
[TBL] [Abstract][Full Text] [Related]
20. The promise of targeted {alpha}-particle therapy.
Mulford DA; Scheinberg DA; Jurcic JG
J Nucl Med; 2005 Jan; 46 Suppl 1():199S-204S. PubMed ID: 15653670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
